News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Terapias_Avanzadas_AseBio
VIVEbiotech achieves significant business growth in 2023 with increases in demand for its lentiviral vector specialization and capabilities
Healthcare · Drug discovery · Innovative drugs · Advanced therapies
Recent company sales grow by 70%, reflecting expanded capabilities and industry recognition of…
Partners - VIVEbiotech
Biotecnología AseBio Drug Discovery
Biotechnology is behind more than 40% of the active ingredients in medications included in the list of essential drugs in Europe
Healthcare · Drug discovery · Innovative drugs
Over the last 40 years, biotechnology has shaped the landscape of medicine, as evidenced by the…
Imagen_Salud_Mental_Biotech
Innovation in mental health
Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of…
Partners - GENESIS Biomed
Estephan_Arredondo_Córdova
#NewAseBioMember | "AseBio is a key reference entity in the Spanish and European biotechnology sector"
Corporate
Meet BeCytes Biotechnologies, our new member. We talked with Estephan Arredondo…
AseBio - BeCytes Biotechnologies
María_Sanjuanbenito_Jori_Armengol
#NewAllyAseBio | "AseBio represents the meeting place for all the companies in the biotech sector at a national level"
Corporate
Meet JORI & ARMENGOL, our new ally. We talked to María Sanjuanbenito,…
Científico_Biotecnología_AseBio
Why is the establishment of a High Commissioner for Deep Strategic Technologies crucial for the future of the Spanish biotechnological industry?
Healthcare · Agrifood · Industrial biotechnology · Financing
In a context where these innovations are advancing rapidly, Spain needs to modernize programs and…
Oryzon_AseBio
ORYZON awarded with a grant for ORY-4001 from the ALS Association in the U.S.
Healthcare · Innovative drugs
To explore Oryzon’s clinical candidate ORY-4001 in ALS. The ALS Association to provide 500,000 USD…
Partners - Oryzon Genomics
Ana_Isabel_Jiménez_Sylentis
"The RNA is being investigated as a promising tool for the treatment of various diseases, including cancer"
Healthcare · Access to innovation · Advanced therapies
We spoke with Ana Isabel Jiménez, General Director of Sylentis, to learn how mRNA technology…
allox-asabys-noticia-biotech-asebio
ALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of Asabys
Healthcare · Access to innovation
The company is developing a proprietary platform technology to design new drugs targeting protein…
Partners - Asabys Partners